L.6. Promoting integrated and coherent systems of scientific evidence-based public health responses to drug use Chair: Informal discussions this morning on a number of resolutions. We will continue until 5:45pm, so that I can discuss with the sponsors during the last 15 minutes. Tomorrow morning, we will suspend our work during the CND’s votes on …
chair
Plenary – Thursday afternoon session
Item 9. Contributions by the Commission to the work of the Economic and Social Council, including follow-up to and review and implementation of the 2030 Agenda for Sustainable Development Secretary: As you were saying, Mr. Chair, the ECOSOC coordination session was held in february and we supported the chair of the CND in his presentation …
Plenary — Tuesday afternoon session
Item 4. Strategic management, budgetary and administrative questions China: The Chinese government has consistently supported and actively participated in drug control efforts advocated by UNODC. UNODC has played an important role in supporting member states and taking measures to address the drug problems and provide technical assistance. China appreciates the positive efforts and results seen …
Plenary: Item 3 General Debate (Tuesday 13th – Morning Session)
Mexico: We meet because of our interest to tackle the World Drug Problem. Aware of the progress made so far, Mexico would like to strengthen the work of the CND in ordinary meetings, subsidiaries and intersessional. For Mexico it is important to replicate the good practice of this process. The implementation of the UNGASS document is …